Montair 5mg Chewable Tablet (Montelukast 5mg)
$45.00 – $122.00Price range: $45.00 through $122.00
| Country of Origin | India |
|---|---|
| Dosage Form | Chewable Tablets |
| Equivalent Brand | Singulair |
| Generic Name | Montelukast |
| Indication | Asthma prevention, Sneezing and runny nose due to allergies |
| Manufacturer | Cipla Ltd |
| Packaging | 15 tablets in 1 strip |
| Composition | Montelukast (5mg) |
| Pack Size | 45 Tablet/s, 90 Tablet/s, 135 Tablet/s |
| Montair 5mg Chewable Tablet (Montelukast 5mg) | |||
| Pack Size | Price | Price/Unit | Add To Cart |
| 45 Tablet/s | $45.00 (1/unit) | $1 | |
| 90 Tablet/s | $84.00 (0.93/unit) | $0.93 | |
| 135 Tablet/s | $122.00 (0.9/unit) | $0.9 | |
Montair 5mg Chewable Tablet is a prescription medicine commonly used to help control asthma symptoms and allergic rhinitis in appropriate pediatric patients. It contains montelukast, a leukotriene receptor antagonist that helps reduce the effects of leukotrienes, inflammatory chemicals involved in airway narrowing, swelling, and allergy symptoms. FDA labeling for montelukast 5-mg chewable tablets identifies the strength for children 6–14 years old for appropriate indications.
What is Montair 5mg Chewable Tablet?
Montair 5mg Chewable Tablet contains montelukast in a convenient chewable formulation. Healthcare professionals may prescribe montelukast as part of a treatment plan for asthma or allergic rhinitis. It can help control inflammation and symptoms over time, but it does not provide immediate relief during a sudden asthma attack. Patients should keep their prescribed rescue medicine available when appropriate.
Because this medicine requires an individualized treatment plan, parents and caregivers should follow the prescribing clinician’s directions carefully. Do not change the dose, frequency, or treatment duration without professional advice.
How does Montair 5mg Chewable Tablet work?
The active ingredient, montelukast, blocks leukotriene receptors. Leukotrienes can contribute to airway inflammation, bronchoconstriction, nasal congestion, and other allergy-related symptoms. By blocking these effects, montelukast can help reduce airway inflammation and improve control of certain respiratory and allergic conditions.
Montair 5mg Chewable Tablet is therefore a controller-type medicine rather than an emergency treatment. It works as part of ongoing disease management rather than providing rapid relief from acute breathing difficulty.
Uses of Montair 5mg Chewable Tablet
Doctors may prescribe Montair 5mg Chewable Tablet for appropriate patients when montelukast is suitable for their condition. Montelukast has labeled uses that include chronic asthma treatment and prevention, prevention of exercise-induced bronchoconstriction in eligible patients, and relief of allergic rhinitis symptoms.
For allergic rhinitis, symptoms may include sneezing, runny nose, nasal congestion, and itching. For asthma, the medicine forms part of a long-term control strategy. Your clinician should determine whether montelukast is appropriate, particularly because treatment choices depend on age, symptoms, severity, other medicines, and individual medical history.
Benefits of Montair 5mg Chewable Tablet
One practical benefit of Montair 5mg Chewable Tablet is its chewable dosage form, which can be easier for children who have difficulty swallowing conventional tablets. The 5-mg strength is specifically used in certain pediatric age groups according to prescribing information.
Montelukast may help reduce allergy-related airway inflammation and support better control of asthma symptoms. When prescribed for allergic rhinitis, it can help address symptoms caused by allergic inflammation. Consistent use according to the prescribed schedule can help maintain treatment benefits.
Related ProductÂ
How to take Montair 5mg Chewable Tablet
Take Montair 5mg Chewable Tablet exactly as prescribed. The appropriate dose and timing depend on the patient’s age and medical condition. FDA prescribing information lists one 5-mg chewable tablet once daily for children 6–14 years old for relevant indications.
Do not give an extra tablet if a dose is missed unless a healthcare professional specifically instructs you to do so. Never use a higher-strength tablet to replace the prescribed dose.
For asthma, montelukast is generally administered once daily in the evening. For allergic rhinitis, the timing can follow the clinician’s instructions.
Important safety information
Montair 5mg Chewable Tablet should not be used to treat a sudden asthma attack. A prescribed quick-relief inhaler or other emergency treatment should be used according to the patient’s asthma action plan.
Montelukast also carries an important warning concerning neuropsychiatric effects. Changes in behavior, mood, sleep, or mental health can occur in some patients. Parents and caregivers should watch for unusual agitation, aggression, anxiety, depression, abnormal dreams, sleep problems, or suicidal thoughts or behavior and promptly contact the healthcare professional if concerning changes occur. The clinician should evaluate the benefits and risks of continuing treatment when such effects develop.
The 5-mg chewable formulation can contain phenylalanine because it may contain aspartame. Patients with phenylketonuria should discuss this with their healthcare professional before use.
Possible side effects
Some patients taking Montair 5 mg Chewable Tablet may experience headache, abdominal discomfort, cough, fever, upper respiratory symptoms, diarrhea, or other adverse effects. The prescribing information also highlights neuropsychiatric reactions as an important safety consideration.
Seek prompt medical attention for severe breathing difficulty, facial or throat swelling, severe allergic reactions, or serious behavioral or mental-health changes. Report persistent or troublesome side effects to the prescribing clinician.
Who should discuss this medicine with a healthcare professional?
Before using Montair 5mg Chewable Tablet, tell the healthcare professional about allergies, existing medical conditions, current medicines, and previous reactions to montelukast. Parents should provide an accurate medication history, including prescription medicines, over-the-counter products, and supplements.
Do not abruptly replace inhaled or oral corticosteroid therapy with montelukast unless the prescribing clinician provides a specific treatment plan.
Frequently Asked Questions
1. Is Montair 5mg Chewable Tablet an antibiotic?
No. Montair 5mg Chewable Tablet contains montelukast, a leukotriene receptor antagonist. It does not treat bacterial infections.
2. Can Montair 5mg Chewable Tablet stop an asthma attack?
No. It is not an emergency rescue medicine. Use the patient’s prescribed quick-relief treatment for acute symptoms and seek emergency care when necessary.
3. Who commonly receives the 5-mg chewable strength?
The FDA labeling for montelukast identifies the 5-mg chewable strength for children 6–14 years old for appropriate indications. The correct treatment should always come from the child’s healthcare professional.
4. Can I give an extra dose if symptoms continue?
No. Do not increase the dose without medical advice. Persistent symptoms may require reassessment of the treatment plan.
5. Does Montair 5mg Chewable Tablet cure asthma permanently?
No. Montair 5mg Chewable Tablet helps control certain respiratory and allergic conditions; it does not permanently cure asthma.




Reviews
There are no reviews yet.